---
figid: PMC7709995__ADVS-7-2002365-g012
figtitle: Engineering Prodrug Nanomedicine for Cancer Immunotherapy
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC7709995
filename: ADVS-7-2002365-g012.jpg
figlink: pmc/articles/PMC7709995/figure/advs2125-fig-0012/
number: F12
caption: a) Schematic illustration of the therapeutic modalities and component structure
  of NCP@pyrolipid prodrug NPs; b) NCP@pyrolipid‐mediated combination of three therapeutic
  modalities for triggering ICD of the tumor cells and blockading PD‐1/PD‐L1 pathway.
  Reproduced with permission.[] Copyright 2016, Springer Nature.
papertitle: Engineering Prodrug Nanomedicine for Cancer Immunotherapy.
reftext: Bin Yang, et al. Adv Sci (Weinh). 2020 Dec;7(23):2002365.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8241692
figid_alias: PMC7709995__F12
figtype: Figure
redirect_from: /figures/PMC7709995__F12
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7709995__ADVS-7-2002365-g012.html
  '@type': Dataset
  description: a) Schematic illustration of the therapeutic modalities and component
    structure of NCP@pyrolipid prodrug NPs; b) NCP@pyrolipid‐mediated combination
    of three therapeutic modalities for triggering ICD of the tumor cells and blockading
    PD‐1/PD‐L1 pathway. Reproduced with permission.[] Copyright 2016, Springer Nature.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DOPA
  - 1,2-distearoyl-sn-glycero
  - 3-phosphocholine
  - Cholesterol
  - 1,2-distearoyl-sn-glycero-3
  - phosphoethanolamine polyethylene
  - glycol
  - Oxaliplatin
  - PDT
  - Necrosis
---
